Denis Guttridge to Sarcoma, Ewing
This is a "connection" page, showing publications Denis Guttridge has written about Sarcoma, Ewing.
Connection Strength
0.282
-
Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models. Pediatr Blood Cancer. 2018 Feb; 65(2).
Score: 0.142
-
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PLoS One. 2017; 12(7):e0181885.
Score: 0.140